Charles River Labs Intl buy Citigroup Inc.
Start price
09.07.25
/
50%
€135.75
Target price
09.07.26
€170.62
Performance (%)
49.76%
End price
10.07.26
€203.30
Summary
This prediction ended on 10.07.26 with a price of €203.30. The BUY prediction by Citigroup_Inc_ for Charles River Labs Intl saw massive gains of 49.76%. Citigroup_Inc_ has a follow-up prediction for Charles River Labs Intl where he still thinks Charles River Labs Intl is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Charles River Labs Intl | 2.378% | 2.378% | 82.396% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $200.00 price target on the stock, up previously from $150.00.
Ratings data for CRL provided by MarketBeat
In the thread Trading Charles River Labs Intl
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€194.00
08.07.26
08.07.26
-
08.07.27
08.07.27
28.71%
20.08.26
20.08.26
Stopped prediction by Citigroup_Inc_ for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€175.45
01.10.24
01.10.24
€158.03
01.10.25
01.10.25
-17.50%
02.10.25
02.10.25